Limb-Girdle Muscular Dystrophy Type 2 Clinical Trials in Seattle, Washington

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)